首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1448218

全球神經設備市場規模、佔有率、成長分析、按產品、最終用戶 - 產業預測，2024-2031 年

Global Neurology Devices Market Size, Share, Growth Analysis, By Product(Neurostimulation Devices, Neurosurgery Devices), By End User(Hospitals, Neurology Clinics) - Industry Forecast 2024-2031

出版日期: 2024年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經設備市場規模為145.8億美元，從2023年的157.6億美元成長到2031年的293.9億美元，預測期間（2024-2031年）複合年成長率為8.1%。

許多神經系統疾病，包括癲癇、創傷性腦損傷、脊髓損傷、帕金森氏症和阿茲海默症，是旨在識別、預防和治療這些疾病的神經病學儀器的焦點。神經設備對於改善神經系統疾病患者的治療結果和生活品質至關重要。該設備的目的是為醫療保健專業人員提供用於診斷和治療神經系統疾病的尖端設備和技術。這些工具可以幫助支持治療性介入、識別異常情況並追蹤症狀的進程。除了促進早期診斷和早期治療之外，這些技術還增強了患者照護並提供卓越的臨床結果。

由於神經系統疾病盛行率的上升和早期診斷需求的增加，市場正在擴大。癲癇和中風的盛行率不斷增加，增加了對神經設備的需求。此外，對改善患者治療效果的有效診斷和治療方法的需求日益成長。神經設備的昂貴性質和獲得監管批准的嚴格要求進一步阻礙了市場擴張。

此外，由於技術進步和創新醫療設備公司，該行業正在不斷發展。作為從業者和研究人員，我們必須不斷研究新的醫療設備，因為對改善患者預後並提供準確診斷的先進設備的需求不斷成長。政府擴大醫療設備產業的舉措、增加醫療設施建設的資金以及擴大醫療設備領域的研發活動都促進了市場的成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Medtronic（US）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
Koninklijke Philips NV（Netherlands）
Siemens Healthineers AG（Germany）
Stryker Corporation（US）
GE Healthcare（US）
Johnson & Johnson（US）
Zimmer Biomet Holdings, Inc.（US）
Nihon Kohden Corporation（Japan）
Hitachi, Ltd.（Japan）
Brainlab AG（Germany）
Elekta AB（Sweden）
LivaNova PLC（UK）
Nevro Corp.（US）
Natus Medical Incorporated（US）
Penumbra, Inc.（US）
Integra LifeSciences Holdings Corporation（US）
Terumo Corporation（Japan）
Neuropace, Inc.（US）

簡介目錄

Product Code: SQMIG35A2500

Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

Numerous neurological conditions, including epilepsy, traumatic brain damage, spinal cord injury, Parkinson's disease, and Alzheimer's disease, are the focus of neurology devices, which are designed to identify, prevent, and cure these conditions. In order to improve patient outcomes and the quality of life for individuals with neurological illnesses, the neurology device is essential. The purpose of this gadget is to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of neurological conditions. These tools support therapeutic intervention, help identify anomalies, and track the course of the condition. In addition to facilitating early diagnosis and treatment, these technologies enhance patient care and yield superior clinical results.

The market is expanding as a result of the rising incidence of neurological disorders and the increased demand for early diagnosis. The need for neurological devices is growing due to the increased prevalence of epilepsy and stroke. Furthermore, there is a growing need for efficient diagnostic and therapeutic approaches that improve patient outcomes. The expensive nature of neurological devices and the strict requirements for obtaining regulatory clearances further impede market expansion.

Additionally, the industry is growing due to technological advancements and innovative medical device companies. As a medical practitioner and researcher, you should always be researching new medical devices because there is a growing need for advanced equipment that improve patient outcomes and provide precise diagnoses. The government's initiative to expand the medical device industry, the rise in finances for the construction of healthcare facilities, and the expansion of research and development activities in the medical device sector all contribute to the growth of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices Market Beverage Packaging Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurology Devices Market Segmental Analysis

The product, end user, and geographic segments of the worldwide neurology devices market are separated out. The market is divided into product categories, including cerebrospinal fluid devices, neurosurgical devices, neurostimulation devices, and interventional neurology devices. The market is divided into ambulatory care centers, neurology clinics, and hospitals based on the end user. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Neurology Devices Market

The need for neurology devices is still being driven by the rising incidence of neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease. The World Health Organization (WHO) states that millions of individuals worldwide suffer from neurological illnesses, which calls for cutting-edge treatment and diagnostic options.

Restraints in the Global Neurology Devices Market

The market for neurology devices is subject to stringent regulations, which include gaining permission from regulatory bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). For smaller producers, complying with these laws can be difficult and expensive, which could impede the expansion of the industry.

Market Trends of the Global Neurology Devices Market

Transition to Less Invasive Techniques In the discipline of neurology, there is a discernible shift toward minimally invasive methods. Benefits of minimally invasive procedures include fewer surgical problems, shorter hospital stays, and faster recuperation periods. The need for neurological devices that allow for precise manipulations with less tissue injury is being driven by this trend.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurology Devices Market by Product

Market Overview
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Devices
and Others

Global Neurology Devices Market by End User

Market Overview
Hospitals
Neurology Clinics
and Ambulatory Care Centers

Global Neurology Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments